Home > Authors > Soumonty Kanungo

Soumonty Kanungo

  • Abbott Healthcare, GlaxoSmithKline hit most by fresh control on drug prices

    Pharma market worth Rs 123 crore under price control as NPPA caps prices of 52 drugs

    Saturday, 13 December 2014 - 6:50am
  • 5 things to do in Kolkata

    Kolkata, or Calcutta, was the capital city of the British India till 1911. The city has a rich historical background and a strong cultural diversity, thanks to the Bengal Renaissance and the Anglo-Islamic influences. And till date, the first thing to notice if one tries to explore the city is the...

    Friday, 12 December 2014 - 6:53pm
  • Now, own a luxurious branded apartment priced at Rs 30-100 crore

    Provenance Land that owns Four Season hotels has invested approximately $100 million and $150 million for the private residences and serviced apartments to be constructed in Mumbai

    Friday, 12 December 2014 - 7:40am
  • Pharma Authority brings 52 formulations under price control

    The National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling and retail prices of 52 more formulation packs in the scheduled category under the Drugs Price Control Order (DPCO), 2013.

    Friday, 12 December 2014 - 6:40am
  • Pharma authority probes spike in price of cardiac stents

    Asks companies to furnish pricing data in three days

    Monday, 8 December 2014 - 7:30am
  • Now, Dr Reddy's Andhra Pradesh unit under USFDA scanner

    The US Food and Drug Administration (FDA) has issued a Form 483 to Hyderabad-based Dr Reddy's Laboratories where the drug regulator raised inspectional observations at the latter's active pharmaceutical ingredients (API) facility located in the Srikakulam district of Andhra Pradesh. The...

    Thursday, 27 November 2014 - 7:20am
  • Empty capsules lead to Aurobindo drug recall

    Co aker joins long list of Indian pharma companies that have recalled drugs in the US market since January

    Wednesday, 26 November 2014 - 6:25am
  • With Cipla, we are looking at long-term play on foreign turf: Adar Poonawalla

    Leading vaccine manufacturer Serum Institute of India (SII) has recently signed a distribution agreement with pharma major Cipla's European subsidiary Cipla Europe NV to market its paediatric vaccine in the European markets. While the paediatric range includes vaccines for measles-mumps-rubella (...

    Tuesday, 25 November 2014 - 6:35am
  • Government planning to control prices of anti-cancer drugs

    In a bid to make a dozen anti-cancer drugs affordable to the masses, the National Pharmaceutical Pricing Authority (NPPA) has invited comments from the pharmaceutical industry and other stakeholders to bring these drugs under price control. As per the recommendations by Mumbai's Tata Memorial...

    Sunday, 23 November 2014 - 7:00am
  • Cipla in pact with Serum Institute to boost vaccines play

    Cipla, India's second largest drugmaker, said its European subsidiary Cipla Europe NV has signed a distribution agreement with Serum Institute of India (SII) for marketing the latter's vaccines in the European market. While both the companies will start with paediatric vaccines distribution, they...

    Friday, 21 November 2014 - 7:20am